Exploring the role of CYP2C19*2 (rs4244285)gene polymorphism in diazepam pharmacokinetics among Turkish Alcohol Withdrawal Syndrome patients

Özkan-Kotiloğlu, S., Kaya-Akyüzlü, D., Yıldırım, M., Danışman, M., Bozmaoğlu, C., Tok, K., Gümüştaş, M., Özgür-İlhan, İ., & Süzen, S. (2025). Exploring the role of CYP2C19*2 (rs4244285)gene polymorphism in diazepam pharmacokinetics among Turkish Alcohol Withdrawal Syndrome patients. Toxicology Letters, 411, S90-S91. https://doi.org/10.1016/j.toxlet.2025.07.243

Özkan-Kotiloğlu S, Kaya-Akyüzlü D, Yıldırım M, Danışman M, Bozmaoğlu C, Tok K, et al. Exploring the role of CYP2C19*2 (rs4244285)gene polymorphism in diazepam pharmacokinetics among Turkish Alcohol Withdrawal Syndrome patients. Toxicology Letters. 2025;411:S90-S91. doi:10.1016/j.toxlet.2025.07.243

Özkan-Kotiloğlu, S., D. Kaya-Akyüzlü, M.A. Yıldırım, M. Danışman, C. Bozmaoğlu, K.C. Tok, M. Gümüştaş, İ. Özgür-İlhan, and S. Süzen. 2025. “Exploring the role of CYP2C19*2 (rs4244285)gene polymorphism in diazepam pharmacokinetics among Turkish Alcohol Withdrawal Syndrome patients.” Toxicology Letters 411: S90-S91. https://doi.org/10.1016/j.toxlet.2025.07.243.

Özkan-Kotiloğlu, S., et al. “Exploring the role of CYP2C19*2 (rs4244285)gene polymorphism in diazepam pharmacokinetics among Turkish Alcohol Withdrawal Syndrome patients.” Toxicology Letters, vol. 411, 2025, pp. S90-S91. https://doi.org/10.1016/j.toxlet.2025.07.243.

Özkan-Kotiloğlu, S., Kaya-Akyüzlü, D., Yıldırım, M., Danışman, M., Bozmaoğlu, C., Tok, K., Gümüştaş, M., Özgür-İlhan, İ. and Süzen, S. (2025) ‘Exploring the role of CYP2C19*2 (rs4244285)gene polymorphism in diazepam pharmacokinetics among Turkish Alcohol Withdrawal Syndrome patients’, Toxicology Letters, 411, pp. S90-S91. doi:10.1016/j.toxlet.2025.07.243.